5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The market is segmented by Type (Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Genetic Testing, Toxicology Testing, Immunology Testing, Neurology Testing, Others), and Technology.
Esoteric testing allows the analysis of rare substances or molecules that are not performed in a routine clinical lab. Many large commercial lab companies outsource complex tests to reference and esoteric testing labs. However, as technology continues to expand laboratory testing, tests that are considered esoteric today may become routine in just a few years. This is often the result of work performed by dedicated research and development scientists.
Recently due to the increasing geriatric population and other factors, the prevalence of chronic and infectious diseases has increased substantially. As a result, demand for specialized early disease diagnostics tests has increased. This has resulted in increased innovation and development in the esoteric testing for diagnostic purposes. These factors have hence helped the growth of the market.
However, the high price of the diagnostic procedure has limited the growth of the market
As per the scope of the report, esoteric testing allows the analysis of rare substances or molecules that are not performed in a routine clinical lab. These are additional tests ordered when a physician requires additional detailed information, outside routine lab testing, to complete a diagnosis, establish a prognosis or choose and monitor a therapeutic regimen. Esoteric testing generally requires sophisticated instruments and materials as well as specialized personnel to perform and analyze results. The tests are typically outsourced to independent, specialized clinical reference laboratories.
In the report, a detailed analysis of the united states esoteric testing market is provided. The market is evaluated by collating revenues generated across segments, categorized by Type, Technology, and Geography.
|Infectious Diseases Testing|
|Enzyme-Linked Immunosorbent Assay|
Report scope can be customized per your requirements. Click here.
Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly, from one person to another. Zoonotic diseases are infectious diseases of animals that can cause disease when transmitted to humans.
Recently, the cases of certain infectious diseases in the United States have increased. For instance, the reported cases of hepatitis A viral infection was reported to be 3,365 in 2017, which is higher as compared to 1,670 cases reported in 2010. Similarly, the reported cases of hepatitis C viral infection increased from 849 in 2010 to 4,225 in 2017. An increase in infectious diseases is expected to boost the esoteric testing market in the United States.
To understand key trends, Download Sample Report
United States is a developed country. It encourages innovation, research and development. Moreover, the adoption rate of newer technologies is also high in the US. As result, the US not only enjoys the presence of global players, but also many domestic companies have been very competitive in the market.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic and Infectious Diseases
4.2.2 Rising Demand for Early Disease Detection Using Specialized Diagnostic Tests
4.2.3 Increasing Funding and Research Grants for the Development of Innovative Esoteric Tests
4.3 Market Restraints
4.3.1 High Price of Esoteric Testing Procedures
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type
5.1.1 Infectious Diseases Testing
5.1.2 Endocrinology Testing
5.1.3 Oncology Testing
5.1.4 Genetic Testing
5.1.5 Toxicology Testing
5.1.6 Immunology Testing
5.1.7 Neurology Testing
5.2 By Technology
5.2.1 Chemiluminescence Immunoassay
5.2.2 Enzyme-Linked Immunosorbent Assay
5.2.3 Mass Spectrometry
5.2.4 Real-Time PCR
5.2.5 Flow Cytometry
5.2.7 Other Technologies
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Laboratory Corporation of America
6.1.2 Opko Health Company
6.1.3 Mayo Medical Laboratories
6.1.4 Myriad Genetics
6.1.5 Genomic Health
6.1.6 Miraca Holdings Inc
6.1.7 Fulgent Genetics Inc
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments